Histone deacetylase inhibition has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy

H. Jung, E. Lee, I. Kim, J. H. Song, G. J. Kim

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Histone deacetylase (HDAC) inhibitors have shown beneficial effects in animal models of cardiovascular diseases. We hypothesized that HDAC inhibitor, sodium valproate (VPA), has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy induced by transverse aortic constriction (TAC). Sections of the heart were visualized after hematoxylin and eosin staining, picrosirius red staining and immunohistochemistry. The expression of genes related to cardiac hypertrophy, fibrosis, and oxidative stress was determined by quantitative real-time polymerase chain reaction. The aortic ring tension analysis was conducted using both the ascending aorta and descending thoracic aorta. TAC increased the expression of hypertrophic, fibrotic, and oxidative stress genes, which was attenuated by VPA. In the ascending aorta with intact endothelium, there was a significant decrease in the relaxation response, which was recovered by VPA treatment. These results indicate that VPA has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy.

Original languageEnglish
Pages (from-to)727-737
Number of pages11
JournalPhysiological Research
Volume68
Issue number5
DOIs
StatePublished - 2019

Keywords

  • Cardiac hypertrophy
  • Fibrosis
  • Histone deacetylase inhibitors
  • Oxidative stress
  • Vascular endothelium
  • Ventricular remodeling

Fingerprint

Dive into the research topics of 'Histone deacetylase inhibition has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy'. Together they form a unique fingerprint.

Cite this